Psych Vivas · Psychopharmacology — lithium
Lithium — consultant viva
Fellowship viva covering lithium efficacy, TDM, organ monitoring, interactions, pregnancy, toxicity and EXTRIP.
On this page & tools
Target exams
Station structure
Time: 8–10 minutes. Depth: consultant teaching registrar. Expect named trials, 12-hour trough discipline, organ monitoring (not levels alone), interaction ladder, modern pregnancy absolute-risk framing, and EXTRIP language without inventing one hospital's exact mmol/L as universal law beyond published EXTRIP thresholds.[1][2][6][7]
Core questions and model points
-
Why lithium for bipolar maintenance? Relapse prevention evidence (Geddes lineage); BALANCE: lithium ± valproate superior to valproate alone for any episode. Guideline first-line theme when monitoring feasible.[1][8]
-
Suicide? Cipriani 2013: fewer suicides and all-cause deaths vs placebo in RCTs of mood disorders — still part of full risk plan.[2]
-
How do you sample levels? 12-hour trough at steady state; TDM culture (AGNP). Maintenance scaffold often 0.6–0.8 mmol/L; older adults lower.[7][8]
-
What else do you monitor? eGFR/creatinine, TFT, calcium — McKnight: NDI/concentrating defect, hypothyroidism, hyperparathyroidism, weight. Shine long-term laboratory signal reinforces this.[3][8]
-
New NSAID or thiazide? Levels can rise; plan level check and counselling; toxicity risk with dehydration.[6][8]
-
Pregnancy? Patorno: modest increased cardiac malformation risk first trimester with dose relationship teaching; Munk-Olsen: major malformation and neonatal readmission signals; balance against high relapse risk if stopped — perinatal psychiatry plan.[4][5]
-
Toxicity and dialysis? Stop lithium; saline if depleted; charcoal does not bind Li+; EXTRIP criteria for ECTR; HD preferred; rebound after dialysis.[6]
Pass criteria
- BALANCE and Cipriani one-liners correct.[1][2]
- 12-hour trough automatic; organ monitoring beyond level only.[3][7]
- Interaction ladder (NSAID/ACEI/ARB/thiazide/dehydration) fluent.[6][8]
- Pregnancy counselled with modern absolute-risk framing, not panic mythology.[4][5]
- EXTRIP named for severe poisoning.[6]
References
- [1]BALANCE investigators and collaborators, Geddes JR, Goodwin GM, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet, 2010.PMID 20092882
- [2]Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ, 2013.PMID 23814104
- [3]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
- [4]Patorno E, Huybrechts KF, Bateman BT, et al. Lithium Use in Pregnancy and the Risk of Cardiac Malformations N Engl J Med, 2017.PMID 28591541
- [5]Munk-Olsen T, Liu X, Viktorin A, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies Lancet Psychiatry, 2018.PMID 29929874
- [6]Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup Clin J Am Soc Nephrol, 2015.PMID 25583292
- [7]Hiemke C, Bergemann N, Clement HW, et al. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 Pharmacopsychiatry, 2018.PMID 29390205
- [8]Gitlin M Lithium side effects and toxicity: prevalence and management strategies Int J Bipolar Disord, 2016.PMID 27900734